Pharmaceutical composition for treating acute dysphonia

Details Pharmaceutical composition for treating acute dysphonia Pharmaceutical composition for treating acute dysphonia

1990-04-06

1993-06-15

Stone, Jacqueline

Drug, bio-affecting and body treating compositions

Enzyme or coenzyme containing

Multienzyme complexes or mixtures of enzymes

424 9464, 514171, 514179, 514251, 514276, 514718, A61K 37547, A61K 3156, A61K 31525, A61K 31505

Patent

active

052195686

ABSTRACT:
A pharmaceutical composition for the treatment of hoarseness. The composition is administered orally in unit dosage form. It is based on the combination of Varidase (a combination of streptokinase and streptodornase), an antiinflammatory corticosteroid, an antihistamine and an expectorant. The composition may optionally contain vitamins, like vitamin B.sub.1 or Vitamin B.sub.2. The invention further relates to a method for the treatment of hoarseness in humans, which comprises administering an effective quantity of a composition as defined above.

REFERENCES:
Svirskii, Biol. Abstracts, vol. 72, No. 82144 (1981).
Miyakogawa et al, Biol. Abstracts, vol. 71, No. 40002 (1981).
Ito et al, Biol. Abstracts, vol. 84, No. 39420 (1987).
Bienenstock et al, Biol. Abstracts, vol. 65, No. 44078 (1977).
Damonte et al, Biol. Abstracts, vol. 52, No. 111995 (1970).
Polli, Biol. Abstracts, vol. 81, No. 46395, (1985).

Affiliated with

Also associated with

Rating

Pharmaceutical composition for treating acute dysphonia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical composition for treating acute dysphonia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition for treating acute dysphonia will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1040823